Parents and Children Together Preventing Diabetes (PACT PD)
NCT ID: NCT01819493
Last Updated: 2018-08-15
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
33 participants
INTERVENTIONAL
2013-03-31
2015-04-16
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
A Family Based Intervention to Reduce the Risk of Type 2 Diabetes in Children
NCT01146314
Family Partners for Health
NCT01378806
Reduce Obesity and Diabetes
NCT00954577
Obesity Prevention in African American School Children
NCT00061165
A Primary Care Behavioral Approach for Addressing Childhood Overweight
NCT00284557
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
SINGLE_GROUP
PREVENTION
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Standard Family-Based intervention
Families randomized to the Standard Family-based Intervention will receive three-month family YMCA memberships, one orientation training session, access to available equipment and programming at the YMCA, and receive diabetes educational materials from the "Power to Prevent" curriculum via email. Based on our previous experience with AA adults, the investigators anticipate that all families will have access to email either at home or at work. Educational materials will be mailed to families without access to email. The study will also maintain contact with participants by sending holiday and birthday cards, as well as postcard reminders of scheduled data collection visits.
Standard Family-Based intervention
Comparison intervention
Lifestyle Intervention
The lifestyle intervention for adults will involve a dietary weight loss program and an increase in caloric expenditure through moderate PA. Parents will be encouraged to decrease caloric intake in a sound manner to produce a total weight loss of 5%. The PA component will be to promote an increase in family home-based activity.
Children. The study will promote healthy eating behaviors, rather than restrictive eating plans with caloric restrictions.
Lifestyle Intervention
Family-based group lifestyle intervention
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Lifestyle Intervention
Family-based group lifestyle intervention
Standard Family-Based intervention
Comparison intervention
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Parental HbA1c levels (pre-diabetes = 5.7 - 6.4%)
* Parent and their child age 8-10
Exclusion Criteria
* On glucose-lowering drugs
* Currently participating in a supervised weight loss program
* Pregnant or Breastfeeding
* Has conditions limiting participation in the interventions
* Has undergone weight loss surgery
* Unwilling to accept randomization
* Plans to live outside the general area in the next 6 months
8 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
NIH
Wake Forest University Health Sciences
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Bettina Beech, DrPH
Role: PRINCIPAL_INVESTIGATOR
Wake Forest University
Edward Ip, PhD
Role: PRINCIPAL_INVESTIGATOR
Wake Forest University Health Sciences
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Wake Forest Baptist Health
Winston-Salem, North Carolina, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
IRB00021267
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.